US EditionPublished • loading... • Updated
AbbVie to invest $380M in new North Chicago API manufacturing facilities
Summary by chicagoconstructionnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
AbbVie to invest $380M in new North Chicago API manufacturing facilities
Chicago Construction News staff writer AbbVie last week announced plans to invest $380 million to build two new active pharmaceutical ingredient (API) manufacturing facilities at its North Chicago campus. The facilities will integrate advanced manufacturing technologies and artificial intelligence (AI) to support production of next-generation neuroscience and obesity medications. Construction is scheduled to begin in spring 2026, with both facil…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
